Crohn’s Disease: A Proactive Blueprint to Prevent Postsurgical Recurrence

For many people with Crohn’s disease, bowel resection surgery can feel like a fresh start. Your symptoms settle down, inflammation and GI discomfort improve, and life begins to feel manageable again.

But surgery is not a cure. While it removes damaged sections of your intestine, it doesn’t eliminate the underlying inflammatory process driving the disease.

But with the right monitoring and treatment plan, recurrence can often be detected early and managed before symptoms return.

“An anastomosis is the ‘join’ where a surgeon reconnects two healthy ends of bowel after removing a diseased segment,” says Alan Moss, MD, the chief scientific officer at the Crohn’s & Colitis Foundation and a professor of gastroenterology at Boston University’s Chobanian & Avedisian School of Medicine.

In Crohn’s, inflammation has a strong tendency to return right at this junction — usually in the small intestine just upstream from the connection, Dr. Moss says.

• Surgical trauma can trigger localized inflammation.
• Changes in blood flow may affect healing.
• Shifts in gut bacteria after surgery can influence immune activity.

Some of these factors are linked to inflammatory triggers, like bacteria in the microbiome, and some aren’t, Moss says. “This area is a hot spot because it experiences high mechanical stress from passing stool, changes in blood flow and bile acids, and ongoing immune activation — all of which can retrigger Crohn’s disease inflammation at the new junction.”

One of the most important — and often surprising — facts about Crohn’s recurrence is that it usually begins silently.

Inflammation inside the bowel can return even earlier than most patients expect, according to the gastroenterologist Brigid Boland, MD, an assistant professor of medicine at the University of California in San Diego and a spokesperson for the American Gastroenterological Association.

“In some cases within weeks, if we look microscopically, we will see inflammation come back. Typically, that happens before anyone will ever notice any symptoms,” Dr. Boland says.

According to Moss:

• Endoscopic recurrence — or visible inflammation — occurs in 70 to 90 percent of patients within one year.

  [5]

  [6]

• Clinical recurrence — or feeling symptoms — affects more than 40 percent of patients within three to five years.

  [7]

• Roughly one-third of patients may need a repeat surgery by 10 years.

  [8]

Because early recurrence is silent, guidelines emphasize the importance of a proactive treatment plan and planned screening within six months to a year post-operation, Moss says.

“It’s often the only way to detect and treat this quiet inflammation before it progresses and starts causing pain, diarrhea, or blockages again,” he says.

A structured follow-up plan is “absolutely critical” in managing Crohn’s disease post-op, Moss says.

A proactive plan should be built around early follow-up, preventive medication when appropriate, and scheduled monitoring instead of waiting for symptoms to return.

Think of the plan as an opportunity to get on the front foot of the disease the second time around, Boland says. “It’s easier to treat early on than later. It’s really a restart … and a chance to get better control over the disease.”

Another major concern is fragmented care, which a proactive plan can help you avoid, Moss says. “If there is no clear plan shared between the surgeon, gastroenterologist, and patient, warning signs are missed, important lifestyle factors are not addressed and the risk of needing another surgery increases,” he says.

Here’s what the first year should look like.

2-Week Post-Op Check This visit focuses on recovery, according to Boland. Your healthcare team will evaluate your:

• Wound healing
• Nutrition and hydration
• Early complications

It’s less about Crohn’s activity at this point and more about surgical recovery.

3-Month Fecal Calprotectin Test This is a stool test that measures levels of a certain protein that indicates intestinal inflammation. “Three months is a good time where we'll actually start checking for inflammation in more objective ways, such as the fecal calprotectin test to see where we’re at post-operatively,” Boland says.

• Detect early inflammation before symptoms
• Help identify patients at higher risk of recurrence

Throughout the Year During the first year after surgery, you should have regular bloodwork and stool tests, Moss says, and you should discuss staying on medications you and your gastroenterologist have agreed on — with clear guidance about dose, timing, and what to do if you miss a dose.

Moss says you and your doctor should also talk about everyday habits to support your gut health and immune system, including:

• Avoiding smoking or vaping
• Limiting ultra-processed foods and heavy alcohol
• Prioritizing sleep and stress management
• Getting regular, moderate exercise

“I encourage patients to keep open communication with their care team about new symptoms, side effects, mood changes, or big life shifts like pregnancy plans or job changes, so we can adjust the plan before small issues become big setbacks,” he says.

After surgery, treatment strategies typically fall into two categories: prophylactic therapy and endoscopic-driven therapy.

Prophylactic therapy involves starting biologics or other advanced therapies soon after surgery — before inflammation returns.

“It tends to be favored for people at higher risk,” says Moss, including those who smoke, have had prior surgeries, or have more aggressive disease.

Endoscopic-driven therapy takes a "watch and wait" approach until a follow-up colonoscopy to guide treatment decisions.

“We monitor closely and wait to adjust or escalate treatment until we see signs of inflammation on a planned scope,” Moss says.

Your gastroenterologist will discuss which route to take based on your individual risk profile, preferences, and comfort with early biologic therapy, Moss says.

“We do not have direct comparisons of both strategies yet in risk-stratified trials, but there are expert recommendations about who is at higher risk of postoperative recurrence for a ‘prevention’ versus ‘monitor’ approach,” he says.

Boland agrees that risk plays a central role. “We try to figure out who is at higher risk and intervene earlier,” she says. “For others, we monitor closely and treat if needed.”

Medication is only part of the picture. Lifestyle factors, especially smoking, can significantly influence outcomes.

She also points to other sustainable habits, like a healthy diet, gentle exercise, maintaining mental health, and lowering stress.

“A Mediterranean-style diet is often a practical option,” she says, emphasizing whole foods, healthy fats, and limiting processed foods.

• Surgery for Crohn’s disease can bring relief from symptoms, but it does not cure the condition; inflammation often returns at the surgical connection site.
• Recurrence typically begins without any symptoms, which is why scheduled tests, especially the six-month colonoscopy, are crucial for catching inflammation early.
• A personalized treatment plan, guided by early monitoring, preventive medicine, and proactive lifestyle changes, can help prevent complications and reduce the likelihood of future surgeries.